Cargando…
The Use of MAGE C1 and Flow Cytometry to Determine the Malignant Cell Type in Multiple Myeloma
The malignant cell phenotype of Multiple Myeloma (MM) remains unclear with studies proposing it to be either clonotypic B or proliferating plasma cells. Cancer/testis antigen MAGE C1 is being extensively studied in MM and it has been suggested that it is involved in the pathogenesis of the cancer. T...
Autores principales: | Wienand, Kirsty, Shires, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368436/ https://www.ncbi.nlm.nih.gov/pubmed/25793710 http://dx.doi.org/10.1371/journal.pone.0120734 |
Ejemplares similares
-
The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients
por: Shires, Karen, et al.
Publicado: (2021) -
Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012) -
Utility of flow cytometry screening before MRD testing in multiple myeloma
por: Panakkal, Vandana, et al.
Publicado: (2023) -
Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017) -
A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma
por: Robillard, N, et al.
Publicado: (2013)